Proactive and systematic multidimensional needs assessment in patients with advanced cancer approaching palliative care: a study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 02 2020
Historique:
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 10 4 2021
Statut: epublish

Résumé

The benefits of palliative care rely on how healthcare professionals assess patients' needs in the initial encounter/s; crucial to the design of a personalised therapeutic plan. However, there is currently no evidence-based guideline to perform this needs assessment. We aim to design and evaluate a proactive and systematic method for the needs assessment using quality guidelines for developing complex interventions. This will involve patients, their relatives and healthcare professionals in all phases of the study and its communication to offer clinical practice a reliable approach to address the palliative needs of patients. To design and assess the feasibility of an evidence-based, proactive and systematic Multidimensional needs Assessment in Palliative care (MAP) as a semistructured clinical interview guide for initial palliative care encounter/s in patients with advanced cancer. This is a two-phase multisite project conducted over 36 months between May 2019 and May 2022. Phase I includes a systematic review, discussions with stakeholders and Delphi consensus. The evidence gathered from phase I will be the basis for the initial versions of the MAP, then submitted to Delphi consensus to develop a preliminary guide of the MAP for the training of clinicians in the feasibility phase. Phase II is a mixed-methods multicenter feasibility study that will assess the MAP's acceptability, participation, practicality, adaptation and implementation. A nested qualitative study will purposively sample a subset of participants to add preliminary clues about the benefits and barriers of the MAP. The evidence gathered from phase II will build a MAP user guide and educational programme for use in clinical practice. Ethical approval for this study has been granted by the university research ethics committee where the study will be carried out (approval reference MED-2018-10). Dissemination will be informed by the results obtained and communication will occur throughout.

Identifiants

pubmed: 32024792
pii: bmjopen-2019-034413
doi: 10.1136/bmjopen-2019-034413
pmc: PMC7045209
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034413

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J R Soc Med. 2001 Sep;94(9):430-2
pubmed: 11535742
Palliat Med. 2010 Apr;24(3):259-60
pubmed: 20371636
J Clin Oncol. 2015 May 1;33(13):1438-45
pubmed: 25800768
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
Palliat Med. 2014 Jan;28(1):49-58
pubmed: 23695827
Lancet Oncol. 2018 Nov;19(11):e588-e653
pubmed: 30344075
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):337-9
pubmed: 15006905
Cancer. 2011 Dec 1;117(23):5383-91
pubmed: 21563177
Oncologist. 2017 Dec;22(12):1528-1534
pubmed: 28894017
Stat Med. 1995 Sep 15;14(17):1933-40
pubmed: 8532986
Oncologist. 2011;16(5):694-703
pubmed: 21471275
Cancer. 2009 Jul 15;115(14):3302-11
pubmed: 19484795
BMC Health Serv Res. 2014 Oct 04;14:476
pubmed: 25281284
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
BMC Med Res Methodol. 2010 Jul 16;10:67
pubmed: 20637084
J Pain Symptom Manage. 2018 Dec;56(6):831-870
pubmed: 30391049
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
J Adv Nurs. 2019 Feb;75(2):313-326
pubmed: 30168164
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
J Pain Symptom Manage. 2017 Dec;54(6):961-972.e16
pubmed: 28818633
Arch Gen Psychiatry. 1999 Aug;56(8):756-62
pubmed: 10435611
J Palliat Med. 2004 Oct;7(5):611-27
pubmed: 15588352
J Adv Nurs. 2005 Dec;52(5):546-53
pubmed: 16268861
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Palliat Med. 2006 Dec;20(8):727-34
pubmed: 17148527
Lancet Oncol. 2007 May;8(5):430-8
pubmed: 17466900
J Palliat Care. 2013 Winter;29(4):237-43
pubmed: 24601075
Support Care Cancer. 2007 Sep;15(9):1075-85
pubmed: 17318591
Med Clin (Barc). 2001 Jun 30;117(4):129-34
pubmed: 11472684
J Natl Compr Canc Netw. 2014 Dec;12(12):1763-71; quiz 1771
pubmed: 25505216
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
J Clin Oncol. 2012 Mar 10;30(8):880-7
pubmed: 22312101
Ann Oncol. 2018 Jan 1;29(1):36-43
pubmed: 29253069
JAMA. 1997 Feb 26;277(8):678-82
pubmed: 9039890
Cancer. 2008 Feb 15;112(4):934-42
pubmed: 18181099
J Oncol Pract. 2017 Feb;13(2):119-121
pubmed: 28972832
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Int J Clin Pharm. 2016 Jun;38(3):655-62
pubmed: 26846316

Auteurs

Denise Pergolizzi (D)

School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.

Iris Crespo (I)

Department of Basic Sciences, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.

Albert Balaguer (A)

School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
Universitat Internacional de Catalunya, Hospital Universitari General de Catalunya, Barcelona, Spain.

Cristina Monforte-Royo (C)

Nursing Department, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain cmonforte@uic.es.

Alberto Alonso-Babarro (A)

La Paz University Hospital, Madrid Autonomous University, Madrid, Spain.

Maria Arantzamendi (M)

Clínica Universidad de Navarra, Pamplona, Spain.

Alazne Belar (A)

Clínica Universidad de Navarra, Pamplona, Spain.

Carlos Centeno (C)

Clínica Universidad de Navarra, Pamplona, Spain.
Instituto de Cultura y Sociedad, Universidad de Navarra, IdiSNA, Pamplona, Spain.

Blanca Goni-Fuste (B)

Nursing Department, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.

Joaquim Julià-Torras (J)

Institut Català d'Oncologia Badalona, Badalona, Spain.

Marina Martinez (M)

Clínica Universidad de Navarra, Pamplona, Spain.

Dolors Mateo-Ortega (D)

Consorci Sanitari de Terrassa, Terrassa, Spain.

Luis May (L)

Hospital Universitari Arnau de Vilanova, Lleida, Spain.

Deborah Moreno-Alonso (D)

Institut Català d'Oncologia L'Hospitalet, L'Hospitalet, Spain.

Maria Nabal Vicuña (M)

Palliative Care Supportive Team, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

Antonio Noguera (A)

Clínica Universidad de Navarra, Pamplona, Spain.
Instituto de Cultura y Sociedad, Universidad de Navarra, IdiSNA, Pamplona, Spain.

Antonio Pascual (A)

Hospital Universitari Sant Pau, Barcelona, Spain.

Encarnacion Perez-Bret (E)

Fundación Vianorte-Laguna, Madrid, Spain.

Javier Rocafort (J)

Fundación Vianorte-Laguna, Madrid, Spain.

Andrea Rodríguez-Prat (A)

Department of Humanities, School of Humanities, Universitat Internacional de Catalunya, Barcelona, Spain.

Dulce Rodriguez (D)

Hospital Universitari Sant Joan de Reus, Reus, Spain.

Carme Sala (C)

Consorci Sanitari de Terrassa, Terrassa, Spain.

Judith Serna (J)

Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Josep Porta-Sales (J)

Nursing Department, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
Institut Català d'Oncologia Girona, Girona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH